Amgen (AMGN) Tops Q2 EPS by 10c; Boosts FY16 Outlook

Amgen (NASDAQ: AMGN) reported Q2 EPS of $2.84, $0.10 better than the analyst estimate of $2.74. Revenue for the quarter came in at $5.69 billion versus the consensus estimate of $5.58 billion.

GUIDANCE:

Amgen sees FY2016 EPS of $11.10-$11.40. Amgen sees FY2016 revenue of $22.5-22.8 billion. The Street sees EPS of $11.18 and revenue of $22.57 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• UBS Reiterates Buy Rating on Cheniere Energy (LNG)